Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Meifeng Pharmaceutical is a specialized pharmaceutical manufacturer based in Fuzhou, China, focusing on the development and production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Established in 1996, the company operates high-standard GMP-compliant facilities and has built a reputation as a reliable supplier for both domestic and international markets. Its core product portfolio includes small molecule therapeutics for respiratory health, musculoskeletal conditions, and cardiovascular support, with key products such as Ambroxol Hydrochloride and Glucosamine. As a key player in the pharmaceutical supply chain, Fuzhou Meifeng provides contract manufacturing services and high-quality chemical synthesis for various therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzhou Meifeng Pharmaceutical.